By www.marketscagr.com
Global Mucopolysaccharidosis Treatment Market Size, Status And Forecast 2024-2031 Story
108
$ 3900
Mucopolysaccharidosis Treatment Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
Shire (Takeda Pharmaceutical Company Limited) Denali Therapeutics ArmaGen REGENXBIO Inc. Sangamo Therapeutics BioMarin Lysogene Abeona Therapeutics Inc. Ultragenyx Pharmaceutical Genzyme Corporation